Mid-November 2024
Developments and Discoveries
With advances in hematology emerging daily, the 2024 ASH Annual Meeting and Exposition offers hematologists the chance to stay on the cutting edge.
Viewpoints
Editor’s Corner
Peer Review and the Yellow Brick Road
Education
Hematologica Obscura
Algorithms in Hematology
Diagnosis and Treatment of Antiphospholipid Syndrome in Pregnancy
Spotlight
ASH Annual Meeting Preview
Scientific Program to Present Sessions on Cutting-Edge Topics, Research Advances
Education Program Provides Framework for Thinking About Patient Care in a Rapidly Changing Field
Studying the Foundations of Aging in Hematologic Disease
Ernest Beutler Lecture Highlights Developments, Future Directions in Gene Therapy for SCD
Experts to Discuss Whether to Treat Smoldering Multiple Myeloma
End-of-Life Care: A Vital Practice for Every Hematologist
Pulling Back the Curtain
Pulling Back the Curtain: Dorothea Douglas Lindsay, MD
pASHions
A Life in Balance: John Seymour, MBBS, PhD
News
In a Different Vein: News from the Blood Journals
Venetoclax Effective for Bridging to Transplant in R/R AML, Study Suggests
Experts Release Guidance on Liver-Related Toxicities With Gene Therapy for Hemophilia A
Literature Scan
Analysis Offers Insights Into Genetics, Mechanisms of Predisposition to MM
Pirtobrutinib Shows Efficacy in Previously Treated Richter Transformation
CLL Precursor Condition Linked with Melanoma Risk
CHIP-Driver Genes Confer Variable Risk for Progression to Therapy-Related Myeloid Neoplasms